Notice names this product. Teva Pharmaceuticals USA’s traZODone Hydrochloride Tablets is named in FDA Class II recall D-0834-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Presence of Foreign Tablets/Capsules Identifying details: Lot: 1394026, Exp. 02/2028.. Units affected: 175,392 bottles. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Presence of Foreign Tablets/Capsules
Company / brand: Teva Pharmaceuticals USA recalls
Affected product: traZODone Hydrochloride Tablets recall status
Official ID D-0834-2026 · Official record ↗
See all Teva Pharmaceuticals USA recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.